MC
CPIX icon

Menta Capital’s Cumberland Pharmaceuticals CPIX Stock Holding History

Menta Capital’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,706
Closed -$57K – 535
2014
Q1 		$57K Sell
12,706
-3,900
-23% -$18.6K 0.02% 369
2013
Q4 		$85K Sell
16,606
-24,500
-60% -$120K 0.04% 348
2013
Q3 		$186K Sell
41,106
-21,100
-34% -$105K 0.09% 307
2013
Q2 		$318K Buy
+62,206
New +$310K 0.2% 198

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
KIM
Kestrel Investment Management San Mateo, California $167M AUM 20.81% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Menta Capital's CPIX Position: Q2 2014 in Review

Menta Capital sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2014, closing a stake of 12,706 shares — an estimated $57K sold.

Menta Capital first reported a position in CPIX in Q2 2013 and held it in 4 quarters. The position peaked at $318K in Q2 2013. 45 funds tracked by Wall St. Rank hold CPIX as of Q2 2014.

  • Menta Capital reported no remaining Cumberland Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Menta Capital sold 12,706 Cumberland Pharmaceuticals shares in Q2 2014, an estimated $57K.
  • Menta Capital first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Menta Capital's Cumberland Pharmaceuticals position peaked at $318K in Q2 2013.
  • 45 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2014.

Based on Menta Capital's 13F filing for Q2 2014, filed 5 Aug 2014.